Nivolumab,Ipilimumab,Cabozantinib,Sunitinib
BMS,Pfizer
['rcc,(-irccs),(-srcc),(-urcc)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'cabo ', 'nivo']
could there be a tail of the curve in cabo nivo for #rcc? cr rate still above 12%. still early but need to follow this! #gu23 
A medical oncologist that specializes in and focuses his research on urologic cancers.